 |
 |

Genetic Factors in Exceptional LongevityReply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In Reply: In response to Drs Andrikopoulos and Richter, the main finding of our study is that families with exceptional longevity have a lipoprotein signature that includes high levels of HDL cholesterol and large HDL and LDL lipoprotein particle sizes. These lipoprotein phenotypes were demonstrated to be associated with decreased prevalence of hypertension, cardiovascular disease (CVD), and the metabolic syndrome. Our study and other studies1 have clearly documented CVD-protective effects of the same lipoprotein phenotypes. Thus, our finding with respect to exceptional longevity and lipoprotein concentrations and particle sizes appears robust and consistent with the burden of the cardiovascular literature.
Because exceptional longevity has a strong genetic component and offspring of exceptionally long-lived individuals also carried the protective lipoprotein phenotype, we further sought to elucidate a potential genetic link; CETP is an obvious candidate gene given its role in reverse cholesterol transport. Our findings showed a statistical association between homozygosity . . . [Full Text of this Article]
Nir Barzilai, MD
barzilai@aecom.yu.edu
Gil Atzmon, PhD
Institute for Aging Research Diabetes Research and Training Center
Clyde Schechter, MA, MD
Department of Family Medicine and Community Health
Richard Lipton, MD
Department of Neurology Albert Einstein College of Medicine New York, NY
Alan R. Shuldiner, MD
University of Maryland School of Medicine Baltimore
RELATED ARTICLES
Genetic Factors in Exceptional Longevity
George K. Andrikopoulos and Dimitri J. Richter
JAMA. 2004;291(8):941-942.
EXTRACT
| FULL TEXT
Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
Nir Barzilai, Gil Atzmon, Clyde Schechter, Ernst J. Schaefer, Adrienne L. Cupples, Richard Lipton, Suzanne Cheng, and Alan R. Shuldiner
JAMA. 2003;290(15):2030-2040.
ABSTRACT
| FULL TEXT
|